APR 12, 2016 3:44 PM PDT

Early PTSD Treatment Quickens Recovery, But Won't Sustain It

WRITTEN BY: Julianne Chiaet
About eight million Americans suffer PTSD each year
Arieh Y. Shalev, MD Making it through a deeply distressing or disturbing experience is painful, complicated, and hard to do. Yet, most people go through a traumatic experience at some point in their lives, and the large majority of those people make it through the trauma and put it behind them. A smaller percentage of people can’t leave the experience behind, no matter how much they want to.

Post-traumatic stress disorder (PTSD) is “a whole-body tragedy,” according to psychotherapist Susan Pease Banitt in her book “The Trauma Tool Kit.” It is “an integral human event of enormous proportions with massive repercussions.” According to the NIH, there are four types of symptoms: re-experiencing, avoidance, arousal and reactivity, and cognition and mood. Re-experiencing symptoms include flashbacks, nightmares, and frightening thoughts. Avoidance symptoms include feeling emotionally numb, having trouble remembering dangerous events, staying away from places that remind the person of the traumatic experience. Arousal and reactivity symptoms include feeling constantly “on edge,” having trouble sleeping, and being startled easily. Lastly, cognition and mood symptoms include having negative thoughts about oneself, having distorted feelings like guilt, and losing interest in once enjoyable activities. 

About eight million Americans suffer PTSD each year; civilian and military population included. “We assume that people living in an otherwise stable environment have better conditions for long-term recovery than individuals who experience lengthy wars or live in a constant state of violence,” said NYU Langone Medical Center psychiatry professor Arieh Y. Shalev, in a press statement. "This might explain part of their spontaneous recovery without initial treatment."

However, new research shows that early treatment for post-traumatic stress accelerates recovery, but it does not sustain it. 

For this study, researchers examined 232 non-military individuals suffering from PTSD after experiencing a single traumatic event. The researchers treated each participant, one month after the traumatic event, using either prolonged exposure therapy, cognitive therapy, selective serotonin reuptake inhibitors (SSRIs), or a placebo pill. The researchers also tracked the participants who declined treatment. 
 

The scientists reassessed the patients at 5 months and at 3 years. They found that patients in the prolonged exposure therapy and cognitive therapy groups experienced significantly less symptoms by 5 months (61 percent better than other groups). Their symptoms didn’t go away, but remained low for three years. The SSRI, placebo, and declined-treatment groups reached the same low level of symptoms by the three-year mark. Thus, early prolonged exposure therapy and cognitive therapy significantly shortened the time to recover. However, those therapies did not reduce the overall three-year prevalence of PTSD.

“What this study tells us, at its core, is that there is a significant public health challenge ahead. Individuals continually expressing initial PTSD symptoms, and who are resistant to early treatment, should be the focus of future research," Shalev said. "They are the ones who remain chronically distressed and disabled, and require care long after their traumatic incident. We need to find ways to identify these subjects, increase the early favorable responses to existing treatment, and find new ways to reduce the long-term burden of PTSD.”

The research was published online on April 12, 2016, in The Journal of Clinical Psychiatry.
 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
SEP 29, 2021
Cell & Molecular Biology
Study Suggests Cell Reprogramming Can Repair Heart Attack Damage
SEP 29, 2021
Study Suggests Cell Reprogramming Can Repair Heart Attack Damage
Cells carry the genome in their nucleus, and the genes that are expressed give a cell its identity. Researchers have bee ...
OCT 03, 2021
Earth & The Environment
Oil Slick Washing Ashore in Southern California
OCT 03, 2021
Oil Slick Washing Ashore in Southern California
This weekend, an oil slick was spotted off the coast of southern California, about three miles from Newport Beach, south ...
OCT 10, 2021
Cell & Molecular Biology
DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients
OCT 10, 2021
DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients
There is a well-known causal connection between smoking and lung cancer, and most research on lung cancer has been focus ...
OCT 17, 2021
Genetics & Genomics
Genes That Cause Disease Seem to Prevent Beneficial Adaptations
OCT 17, 2021
Genes That Cause Disease Seem to Prevent Beneficial Adaptations
A new study has used computational tools to investigate evolution in the human genome that's occurred over the past 50,0 ...
OCT 20, 2021
Plants & Animals
Processed Foods Negatively Affect Memory in Aging Brains
OCT 20, 2021
Processed Foods Negatively Affect Memory in Aging Brains
Processed foods—chips, soda, frozen meals, the kinds of foods designed to have a long shelf life and be easy to pr ...
OCT 22, 2021
Genetics & Genomics
Studying the Evolution of SARS-CoV-2 in One Patient Over 324 Days
OCT 22, 2021
Studying the Evolution of SARS-CoV-2 in One Patient Over 324 Days
To clear a viral infection, the human body has to mount an effective immune response. After detecting the pathogen, immu ...
Loading Comments...